Compare WF & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WF | BIO |
|---|---|---|
| Founded | 1899 | 1952 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.5B | 8.0B |
| IPO Year | 2003 | 1994 |
| Metric | WF | BIO |
|---|---|---|
| Price | $68.31 | $382.79 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $339.75 |
| AVG Volume (30 Days) | 96.3K | ★ 278.6K |
| Earning Date | 04-24-2026 | 04-30-2026 |
| Dividend Yield | ★ 3.71% | N/A |
| EPS Growth | N/A | ★ 142.61 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,583,200,000.00 |
| Revenue This Year | $18.73 | $2.74 |
| Revenue Next Year | $4.33 | $3.20 |
| P/E Ratio | $9.03 | ★ N/A |
| Revenue Growth | N/A | ★ 0.65 |
| 52 Week Low | $48.83 | $236.73 |
| 52 Week High | $84.71 | $380.71 |
| Indicator | WF | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 51.09 | 78.33 |
| Support Level | $63.03 | $289.16 |
| Resistance Level | $71.30 | N/A |
| Average True Range (ATR) | 1.44 | 12.16 |
| MACD | -0.52 | 1.66 |
| Stochastic Oscillator | 27.23 | 93.14 |
Woori Financial Group Inc is a banking and financial services holding company that offers a wide range of businesses, including corporate banking, consumer banking, credit card operations, investment banking, capital markets activities, international banking, asset management, life insurance, and other businesses. It provides products and services to customers, which mainly comprise small- and medium-sized enterprises and individuals, as well as some of Korea's corporations. It has six operational business segments: banking, life insurance, credit card, capital, investment securities, and other operations.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.